Northwestern Medicine scientists have discovered that an existing therapy used to treat Alzheimer’s disease might also work on patients with Primary Progressive Aphasia, a type of dementia that destroys language and currently has no treatment.
According to a recent study, a novel nanoparticle-based drug repaired neurons and improved microvasculature in a mouse model of spinocerebellar ataxia 1, a degenerative disease that affects the cerebellum.
Abnormal activation of a small population of neurons may contribute to motor learning and motor function deficits in patients with Parkinson’s disease, according to a recent study.
Northwestern Medicine investigators discovered a method to modulate levels of a protein that is known to drive inflammation, by manipulating levels of an amino acid known as serine.
A team of scientists has discovered the physiological function of APP, a protein long known to be associated with Alzheimer’s disease but whose normal function had remained elusive.
A one-time stem cell transplantation therapy for multiple sclerosis showed improvements over the current treatment, according to a preliminary trial.
Northwestern was recently awarded a five-year, $13.5 million grant from the National Institutes of Health to create a platform of app-based tools, called the MobileToolbox, to remotely assess cognitive function.
Northwestern Medicine scientists have identified a gene, called isocitrate dehydrogenase 3-alpha, that promotes tumors in grade IV glioblastoma, according to a study published in Science Advances.
The ventral striatum, a small part of the brain’s basal ganglia, directs behavior by assigning a reward dimension to everyday items, according to a recent study.
The 8th Annual Les Turner Symposium brought together investigators, clinicians, patients and families to share the latest discoveries in ALS research, promote scientific collaboration and provide patient education.